Internal Medicine, Hematology · Spartanburg, SC
NPI
1841294121
Since 2005
Specialty
Internal Medicine, Hematology
Code 207RH0000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
101 E Wood St
Spartanburg, SC, 29303
Phone (864) 560-7050
Groups this clinician bills Medicare through
Medicare paid, 2024
$70K
1,058 services
Medicare patients, 2024
399
Average age 75
Drug cost, 2024
$5.5M
1,400 prescriptions
Company payments, 2025
$5,077
From 38 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Asim R Pati was code 99213 (office e&m - established), 265 times for 158 patients. In total Asim R Pati billed 1,058 services in 11 codes, and Medicare paid $70K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-12-01.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Facility | 265 | 158 | $46.81 | $12K |
| 99214 Office E&M - Established | Facility | 263 | 127 | $68.94 | $18K |
| 99213 Office E&M - Established | Office | 179 | 107 | $43.67 | $7,817 |
| 99214 Office E&M - Established | Office | 139 | 62 | $70.97 | $9,864 |
| 99215 Office E&M - Established | Facility | 70 | 54 | $107.42 | $7,520 |
| 99215 Office E&M - Established | Office | 57 | 50 | $111.83 | $6,374 |
| 99233 Hospital E&M - Subsequent | Facility | 30 | 11 | $92.70 | $2,781 |
| 99223 Hospital E&M - Initial | Facility | 14 | 12 | $135.42 | $1,896 |
By year: 2022 $71K for 2,629 services; 2023 $68K for 1,066 services; 2024 $70K for 1,058 services.
Medicare prescription drug claims, 2024
In 2024, the drug Asim R Pati prescribed most often to Medicare patients was Allopurinol, with 166 prescriptions and refills. In total Asim R Pati wrote 1,400 Medicare prescriptions that cost $5.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Allopurinol Generic | 166 | 236 | 39 | $964 |
| Hydroxyurea Generic | 123 | 179 | 29 | $2,246 |
| Revlimid Lenalidomide | 117 | 117 | 17 | $1.8M |
| Eliquis Apixaban | 92 | 134 | 20 | $77K |
| Calquence Acalabrutinib Maleate | 67 | 67 | Under 11 | $891K |
| Imbruvica Ibrutinib | 66 | 67 | Under 11 | $598K |
| Acyclovir Generic | 64 | 94 | 18 | $889 |
| Dexamethasone Generic | 56 | 61 | 13 | $896 |
| Xarelto Rivaroxaban | 50 | 70 | Under 11 | $38K |
| Sprycel Dasatinib | 44 | 44 | Under 11 | $706K |
| Warfarin Sodium Generic | 40 | 69 | Under 11 | $209 |
| Potassium Chloride Generic | 32 | 50 | Under 11 | $311 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 29 | 29 | Under 11 | $513 |
| Gabapentin Generic | 29 | 29 | Under 11 | $364 |
| Levofloxacin Generic | 28 | 36 | Under 11 | $181 |
Brand drugs: - claims; generic drugs: 877 claims; opioid claims: 42.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Asim R Pati $5,077 ($5,077 in general payments such as food, travel and fees) from 38 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $2,085.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 11 | $2,085 |
| Celgene Corporation BMY | 17 | $432 |
| E.R. Squibb & Sons, L.L.C. BMY | 12 | $219 |
| Pfizer Inc. PFE | 10 | $193 |
| Incyte Corporation INCY | 8 | $166 |
| Merck Sharp & Dohme LLC MRK | 6 | $158 |
| Genentech USA, Inc. ROG.SW | 6 | $123 |
| Taiho Oncology, Inc. 4578.T | 6 | $112 |
| BeOne Medicines USA, Inc. ONC | 5 | $111 |
| Seagen Inc. PFE | 1 | $99 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.